Retinal degenerative diseases can be broadly categorized by the anatomical location of the clinically manifested abnormalities. Degeneration in the group of diseases known as retinitis pigmentosa typically proceeds in a peripheral to central gradient. Macular degeneration, in contrast, affects, as the name indicates, the central region of the retina. Macular degeneration causes a loss in central vision, color vision, contrast sensitivity and fine visual discrimination. There is currently no cure for macular degeneration. Treatment for age-related macular degeneration (AMD) and its neovascular complications is hampered by a lack of relevant animal models for macular degeneration or macular dystrophies. Progress in identification of genes causing macular degeneration lags behind that in identifying genes causing retinitis pigmentosa. Recently, however, over six mutations have been detected in the TIMP-3-encoding gene (TIMP-3) in patients with Sorsby's fundus dystrophy (SFD). SFD is a degenerative disease that affects the macula with particular severity. With the identification of a gene defect causing macular degeneration, it becomes possible to generate (an) animal model(s) of the disease and to use these to define the molecular mechanisms which lead to the pathogenic findings. The applicants have recently identified the human TIMP-3 promoter region. Using this to drive mutated versions of a human TIMP-3 cDNA, mice transgenic for mutant human TIMP-3 have been generated. These mice appear to possess several abnormalities observed in SFD patients, including a relatively thick layer of sub-retinal pigment epithelium (RPE) deposits across the entire retina and defects in Bruch's membrane which expand in size over time. Control mice transgenic for wild-type human TIMP-3 have normal retinas. The research proposed here aims to further characterize these transgenic mutant TIMP-3 mice. In addition, using the Cre/lox recombination system, additional lines of mice containing RPE-specific or global TIMP-3 knock-outs will be generated. The pathogenic mechanisms observed in each of the lines of genetically altered mice (and in lines derived from crossing them) will be assessed. The characterization of the pathogenic basis of SFD could suggest therapeutic approaches for treating this disease and other forms of macular degeneration.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY012156-02
Application #
2882950
Study Section
Visual Sciences C Study Section (VISC)
Project Start
1998-03-01
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lebherz, Corinna; Maguire, Albert M; Auricchio, Alberto et al. (2005) Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. Diabetes 54:1141-9
Lebherz, Corinna; Auricchio, Alberto; Maguire, Albert M et al. (2005) Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Hum Gene Ther 16:178-86
Cideciyan, Artur V; Swider, Malgorzata; Aleman, Tomas S et al. (2005) ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci 46:4739-46
Rex, Tonia S; Peet, John A; Surace, Enrico M et al. (2005) The distribution, concentration, and toxicity of enhanced green fluorescent protein in retinal cells after genomic or somatic (virus-mediated) gene transfer. Mol Vis 11:1236-45
Schuettauf, Frank; Vorwerk, Christian; Naskar, Rita et al. (2004) Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity. Curr Eye Res 29:379-86
Dejneka, Nadine S; Surace, Enrico M; Aleman, Tomas S et al. (2004) In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 9:182-8
Wong, Wai T; Rex, Tonia S; Auricchio, Alberto et al. (2004) Effect of over-expression of pigment epithelium derived factor (PEDF) on developing retinal vasculature in the mouse. Mol Vis 10:837-44
Dejneka, Nadine S; Kuroki, Akiko M; Fosnot, Joshua et al. (2004) Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis 10:964-72
Cideciyan, Artur V; Aleman, Tomas S; Swider, Malgorzata et al. (2004) Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 13:525-34
Rex, Tonia S; Allocca, Mariacarmela; Domenici, Luciano et al. (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855-61

Showing the most recent 10 out of 33 publications